New York State Common Retirement Fund
RVMD icon

New York State Common Retirement Fund’s Revolution Medicines RVMD Stock Holding History

New York State Common Retirement Fund’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.7M Buy
131,893
+7,184
+6% +$1.05M 0.03% 396
2026
Q1 		$12.1M Sell
124,709
-4,698
-4% -$474K 0.02% 632
2025
Q4 		$10.3M Buy
129,407
+9,600
+8% +$629K 0.01% 715
2025
Q3 		$5.59M Buy
119,807
+33,821
+39% +$1.32M 0.01% 1011
2025
Q2 		$3.16M Buy
85,986
+25,664
+43% +$986K ﹤0.01% 1245
2025
Q1 		$2.13M Sell
60,322
-3,279
-5% -$133K ﹤0.01% 1352
2024
Q4 		$2.78M Buy
63,601
+7,244
+13% +$366K ﹤0.01% 1302
2024
Q3 		$2.56M Sell
56,357
-33,113
-37% -$1.44M ﹤0.01% 1328
2024
Q2 		$3.47M Buy
89,470
+29,083
+48% +$1.09M ﹤0.01% 1276
2024
Q1 		$1.95M Sell
60,387
-455
-0.7% -$13.5K ﹤0.01% 1486
2023
Q4 		$1.74M Buy
60,842
+18,564
+44% +$446K ﹤0.01% 1524
2023
Q3 		$1.17M Buy
42,278
+75
+0.2% +$2.22K ﹤0.01% 1668
2023
Q2 		$1.13M Sell
42,203
-6,348
-13% -$156K ﹤0.01% 1722
2023
Q1 		$1.05M Sell
48,551
-5,902
-11% -$145K ﹤0.01% 1853
2022
Q4 		$1.3M Buy
54,453
+4,323
+9% +$91.9K ﹤0.01% 1842
2022
Q3 		$989K Buy
50,130
+7,391
+17% +$162K ﹤0.01% 1976
2022
Q2 		$833K Sell
42,739
-95
-0.2% -$1.85K ﹤0.01% 2118
2022
Q1 		$1.09M Buy
42,834
+46
+0.1% +$1K ﹤0.01% 2066
2021
Q4 		$1.08M Sell
42,788
-145
-0.3% -$4.09K ﹤0.01% 2084
2021
Q3 		$1.18M Sell
42,933
-8,416
-16% -$245K ﹤0.01% 2048
2021
Q2 		$1.63M Buy
51,349
+16,449
+47% +$574K ﹤0.01% 1992
2021
Q1 		$1.6M Hold
34,900
– – ﹤0.01% 1907
2020
Q4 		$1.38M Hold
34,900
– – ﹤0.01% 1880
2020
Q3 		$1.22M Buy
34,900
+22,100
+173% +$612K ﹤0.01% 1816
2020
Q2 		$404K Buy
+12,800
New +$402K ﹤0.01% 2323

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

New York State Common Retirement Fund's RVMD Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Revolution Medicines (RVMD) stake by 5.8% in Q2 2026, buying an estimated $1.05M and bringing the position to 131,893 shares worth $24.7M. The position accounts for 0.03% of the portfolio, ranked #396.

New York State Common Retirement Fund first reported a position in RVMD in Q2 2020 and has held it in 25 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • New York State Common Retirement Fund held 131,893 shares of Revolution Medicines worth $24.7M as of Q2 2026.
  • New York State Common Retirement Fund bought 7,184 Revolution Medicines shares in Q2 2026, an estimated $1.05M.
  • Revolution Medicines made up 0.03% of New York State Common Retirement Fund's portfolio in Q2 2026, its #396 holding.
  • New York State Common Retirement Fund first reported a position in Revolution Medicines in Q2 2020 and has held it in 25 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.